Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer

Immunobiology

Volumn 195, Issue 2, 1996, Pages 140-151

  Takenoyama, Mitsuhiro ^a   Yasumoto, Kosei ^a,c   Harada, Mamoru ^a   Matsuzaki, Goro ^a   Izhida, Teruyoshi ^b   Sugimachi, Keizo ^b   Nomoto, Kikuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG CANCER; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEMORY CELL; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029792812     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(96)80034-9     Document Type: Article

References (29)

1. FISHER, B., and E. R. FISHER. 1971. Studies concerning the regional lymph node in cancer. 1. Initiation of immunity. Cancer 27: 1001-1004.
2. HEYS, S. D., and O. EREMIN. 1992. The relevance of tumor draining lymph nodes in cancer. Surg. Gynecol. Obstet. 174: 533-540.
3. ABE, R., and N. TANEICHI. 1972. Lymphatic metastasis in experimental cecal cancer. Arch. Surg. 104: 95-98.
4. BARNA, B., and S. D. DEODHAR. 1975. The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors. Cancer Res. 35: 920-926.
5. LETESSIER, E. M., M. SACCHI, J. T. JOHNSON, R. B. HERBERMAN, and T. L. WHITESIDE. 1990. The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer. Cell Immunol. 130: 446-458.
6. RUBBERT, A., B. MANGER, N. LANG, J. R. KALDEN, and E. PLATZER. 1991. Functional characterization of tumor-infiltrating lymphocytes, lymph-node lymphocytes and peripheral-blood lymphocytes from patients with breast cancer. Int. J. Cancer 49: 25-31.
7. REISS, C. K., F. J. VOLENEC, M. HUMPHREY, O. SINGLA, and L. J. HUMPHREY. 1983. The role of the regional lymph node in breast cancer: A comparison between nodal and systemic reactivity. J. Surg. Oncol. 22: 249-253.
8. TSENG, C. C., Y. NIO, M. TSUBONO, M. FUKUMOTO, and T. TOBE. 1992. Relationships for recombinant interleukin-2-stimulated mixed lymphocyte tumor extract reaction between peripheral blood lymphocytes and regional node lymphocytes in gastric cancer patients. Anticancer Res. 12: 927-932.
9. WATANABE, Y., Y. HASHIZUME, J. SHIMIZU, M. YOSHIDA, S. WATANABE, T. IWA, S. SAKAI, S. MIGITA, H. SATO, T. MURAYAMA, S. KOSHIMURA, and M. SAITO. 1990. Functional character and augmentation of lymphocytes in regional lymph nodes of patients with lung cancer. Am. Rev. Respir. Dis. 142: 769-774.
10. NAKAMURA, H., K. ISHIGURO, and T. MORI. 1988. Different immune functions of peripheral blood, regional lymph node, and tumor infiltrating lymphocytes in lung cancer patients. Cancer 62: 2489-2497.
11. YAITA, H., K. YASUMOTO, A. NAGASHIMA, K. SUGIMACHI, and K. NOMOTO. 1988. Antitumor activity of regional lymph node lymphocytes in patients with lung cancer. J. Surg. Oncol. 38: 165-172.
12. TATAKE, R. J., N. KRISHNAN, R. S. RAO, A. R. FAKIH, and S. G. GANGAL. 1989. Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer. Int. J. Cancer 43: 560-566.
13. YASUMOTO, K., M. OHTA, and K. NOMOTO. 1976. Cytotoxic activity of lymphocytes to bronchogenic carcinoma cells in patients with lung cancer. Gann 67: 505-511.
14. YANAGAWA, E., K. YASUMOTO, H. MANABE, N. NAGANO, N. HIROTA, M. OHTA, T. HATTORI, K. NOMOTO, I. AZUMA, and Y. YAMAMURA. 1979. Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer. Gann 70: 533-539.
15. NAGASHIMA, A., K. YASUMOTO, H. NAKAHASHI, S. TAKEO, T. YANO, and K. NOMOTO. 1987. Antitumor activity of pleural cavity macrophages and its regulation by pleural cavity lymphocytes in patients with lung cancer. Cancer Res. 47: 5497-5500.
16. NAKAHASHI, H., K. YASUMOTO, A. NAGASHIMA, H. YAITA, S. TAKEO, A. MOTOHIRO, T. FURUKAWA, K. INOKUCHI, and K. NOMOTO. 1984. Antitumor activity of macrophages in lung cancer patients with special reference to location of macrophages. Cancer Res. 44: 5906-5909.
17. YOSHINO, I., T. YANO, M. MURATA, T. ISHIDA, K. SUGIMACHI, G. KIMURA, and K. NOMOTO. 1992. Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor. Cancer Res. 52: 775-781.
18. TAKEO, S., K. YASUMOTO, A. NAGASHIMA, H. NAKAHASHI, K. SUGIMACHI, and K. NOMOTO. 1986. Role of Tumor-associated macrophages in lung cancer. Cancer Res. 46: 3179-3182.
19. KUDA, T., K. YASUMOTO, T. YANO, H. NAKAHASHI, K. SUGIMACHI, and K. NOMOTO. 1987. Role of antitumor activity of alveolar macrophages in lung cancer patients. Cancer Res. 47: 2199-2202.
20. SANDERS, M. E., M. W. MAKGABA, and S. SHAW. 1988. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol. Today 9: 195-199.
21. SANDERS, M. E., M. W. MAKGABA, S. O. SHARROW, D. STEPHANY, T. A. SPRINGER, H. A. YOUNG, and S. SHAW. 1988. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-γ production. J. Immunol. 140: 1401-1407.
22. WACHOLTZ, M. C., S. S. PATEL, and P. E. LIPSKY. 1989. Leukocyte function-associated antigen I is an activation molecule for human T cells. J. Exp. Med. 170: 431-448.
23. REINHERZ, E. L., P. C. KUNG, J. M. PESANDO, J. RITZ, G. GOLDSTEIN, and S. F. SCHLOSSMAN. 1979. Ia determinants on human T-cell subsets defined by monoclonal antibody. J. Exp. Med. 150: 1472-1482.
24. OHASHI, Y., T. TAKESHITA, K. NAGATA, S. MORI, and K. SUGAMURA. 1989. Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells. J. Immunol. 143: 3548-3555.
25. ITO, O., M. HARADA, M. TAKENOYAMA, G. MATSUZAKI, and K. NOMOTO. 1996. An increase of B cells in the tumor-bearing state has the potential to induce anti-tumor immunity. Immunobiology 195: 1-15.
26. EREMIN, O., P. ROBERTS, D. PLUMB, and J. P. STEPHENS. 1980. Human regional tumor lymph nodes: Alterations of micro-architecture and lymphocyte subpopulations. Br. J. Cancer 41: 62-72.
27. YASUMOTO, K., H. MANABE, K. NOMOTO, and K. INOKUCHI. 1983. Antibody specific for lung cancer cells detected in sera of patients with bronchogenic carcinoma. Gann 74: 595-601.
28. COZZOLINO, F., M. TORCIA, M. A. CAROSSINO, R. GIORDANI, C. SELLI, G. TALINI, E. REALI, A. NOVELLI, V. PISTOIA, and M. FERRARINI. 1987. Characterization of cells from invaded lymph nodes in patients with solid tumors: lymphokine requirement for tumor-specific lymphoproliferative response. J. Exp. Med. 166: 303-318.
29. HOON, D. S. B., R. J. BOWKER, and A. J. COCHRAN. 1987. Suppressor cell activity in melanoma-draining lymph nodes. Cancer Res. 47: 1529-1533.